{
  "openalex_id": "W3008539615",
  "doi": "https://doi.org/10.7326/acpj202002180-016",
  "title": "Dapagliflozin reduced worsening HF or CV death in HF with reduced ejection fraction",
  "abstract": "ACP Journal Club18 February 2020Dapagliflozin reduced worsening HF or CV death in HF with reduced ejection fractionKristen Sullivan, MD, Harriette G.C. Van Spall, MD, MPH, FRCPCKristen Sullivan, MDMcMaster University, Hamilton, Ontario, Canada (K.S., H.G.V.)Search for more papers by this author, Harriette G.C. Van Spall, MD, MPH, FRCPCMcMaster University, Hamilton, Ontario, Canada (K.S., H.G.V.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJ202002180-016 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationMcMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995-2008. https://pubmed.ncbi.nlm.nih.gov/31535829Clinical Impact RatingsGIM/FP/GP: Cardiology: Reference1 Zelniker TA, Wiviott SD, Raz I, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393:31-9. [PMID: 30424892] Google Scholar Author, Article, and Disclosure InformationAffiliations: McMaster University, Hamilton, Ontario, Canada (K.S., H.G.V.)Disclosures: The commentators have disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-3039.This article was published at Annals.org on 4 February 2020. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 18 February 2020Volume 172, Issue 4Page: JC16KeywordsDrug informationDrug therapyEjection fractionEstimated glomerular filtration rateHeart failureHospitalizationsHypotensionType 1 diabetesType 2 diabetesVital statistics ePublished: 18 February 2020 Issue Published: 18 February 2020 Copyright & PermissionsCopyright Â© 2020 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...",
  "authors": [
    {
      "display_name": "Kristen Sullivan",
      "id": "A5103201899",
      "orcid": "https://orcid.org/0009-0009-2548-5888",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Kristen Sullivan"
    },
    {
      "display_name": "Harriette G.C. Van Spall",
      "id": "A5059416021",
      "orcid": "https://orcid.org/0000-0002-8370-4569",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Harriette G.C. Van Spall"
    }
  ],
  "publication_year": 2020,
  "publication_date": "2020-02-17",
  "type": "letter",
  "cited_by_count": 0,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S119722071",
    "display_name": "Annals of Internal Medicine",
    "issn_l": "0003-4819",
    "issn": [
      "0003-4819",
      "1539-3704"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316812"
  },
  "volume": "172",
  "issue": "4",
  "first_page": "JC16",
  "last_page": "JC16",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.7870419
    },
    {
      "id": "C78085059",
      "display_name": "Ejection fraction",
      "level": 3,
      "score": 0.69604933
    },
    {
      "id": "C2777422806",
      "display_name": "Dapagliflozin",
      "level": 4,
      "score": 0.60414255
    },
    {
      "id": "C2778198053",
      "display_name": "Heart failure",
      "level": 2,
      "score": 0.5486149
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.52196115
    },
    {
      "id": "C164705383",
      "display_name": "Cardiology",
      "level": 1,
      "score": 0.41859734
    },
    {
      "id": "C555293320",
      "display_name": "Diabetes mellitus",
      "level": 2,
      "score": 0.26865613
    },
    {
      "id": "C2777180221",
      "display_name": "Type 2 diabetes",
      "level": 3,
      "score": 0.1709015
    },
    {
      "id": "C134018914",
      "display_name": "Endocrinology",
      "level": 1,
      "score": 0.15587083
    }
  ],
  "topics": [
    {
      "id": "T10401",
      "display_name": "Diabetes Treatment and Management",
      "score": 1.0
    },
    {
      "id": "T10839",
      "display_name": "Pancreatic function and diabetes",
      "score": 0.9855
    },
    {
      "id": "T11339",
      "display_name": "Metabolism, Diabetes, and Cancer",
      "score": 0.9717
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.7326/acpj202002180-016",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T15:54:24.626981",
  "source_database": "OpenAlex"
}